REVO BIOLOGICS

Dead / Cancelled — Cancelled — Section 8 (as of 12 Jul 2024)

What this means for you

This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
85622031
Registration number
4459753
Mark type
Design + words
Filed
10 May 2012
Published for opposition
13 Nov 2012
Registered
31 Dec 2013
Attorney of record
Monte L. Falcoff

Goods and services

  • Class 005 — Pharmaceuticals: [ Pharmaceuticals, biosimilars, biopharmaceutical [ and veterinary ] preparations for the treatment of cancer, blood diseases, auto-immune diseases, infectious diseases and hereditary diseases ]
  • Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals, biosimilars, biopharmaceutical [ and veterinary ] preparations and proteins for the treatment of cancer, blood diseases, auto-immune diseases, infectious diseases and hereditary diseases
  • Class 042 — Scientific and technological services: Research and development of pharmaceuticals, biosimilars, biopharmaceutical [ and veterinary ] preparations and medicines

Owner

Prosecution history

  • 12 Jul 2024 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
  • 31 Dec 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
  • 20 Jul 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
  • 20 Jul 2020 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
  • 10 Jul 2020 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
  • 23 Jan 2020 — POST REGISTRATION ACTION MAILED - SEC. 8
  • 23 Jan 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 17 Dec 2019 — TEAS SECTION 8 RECEIVED
  • 31 Dec 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 12 Mar 2014 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 31 Dec 2013 — REGISTERED-PRINCIPAL REGISTER
  • 26 Nov 2013 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 23 Nov 2013 — LAW OFFICE REGISTRATION REVIEW COMPLETED
  • 22 Nov 2013 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 04 Nov 2013 — TEAS/EMAIL CORRESPONDENCE ENTERED

View this trademark record on Marksy